Mesoblast Limited (NASDAQ:MESO) Q2 2023 Earnings Call Transcript March 2, 2023
Silviu Itescu: Thank you very much, operator. Good afternoon, good morning to everybody. Thank you for joining us on the operational highlights and financial results for the second quarter fiscal year 2023. If we could go to Slide 4, please. On the call with me today is Andrew Chaponnel, our Interim CFO; and Dr. Eric Rose, our Chief Medical Officer. Slide 4 is a snapshot of the investment highlights for the...
